Ioanna Stergiades

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
- Patent number 10,377,751
- Issue date Aug 13, 2019
- Theravance Biopharma R&D IP, LLC
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
- Patent number 9,206,172
- Issue date Dec 8, 2015
- Theravance Biopharma R&D IP, LLC
- Daniel D. Long
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing an intermediate to mu opioid receptor antagon...
- Patent number 8,476,440
- Issue date Jul 2, 2013
- Theravance, Inc.
- Pierre-Jean Colson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists
- Patent number 8,263,618
- Issue date Sep 11, 2012
- Theravance, Inc.
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for preparing an intermediate to mu opioid receptor antagon...
- Patent number 8,247,559
- Issue date Aug 21, 2012
- Theravance, Inc.
- Pierre-Jean Colson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 4-amino-benzylpiperidine compounds
- Patent number 8,080,565
- Issue date Dec 20, 2011
- Theravance, Inc.
- Mathai Mammen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing an intermediate to opioid receptor antagonists
- Patent number 7,932,402
- Issue date Apr 26, 2011
- Theravance, Inc.
- Pierre-Jean Colson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of a β2 adrenergic receptor agonist
- Patent number 7,772,434
- Issue date Aug 10, 2010
- Theravance, Inc.
- Ioanna Stergiades
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
- Patent number 7,622,508
- Issue date Nov 24, 2009
- Theravance, Inc.
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline form of β2 adrenergic receptor agonist
- Patent number 7,557,247
- Issue date Jul 7, 2009
- Theravance, Inc.
- Ioanna Stergiades
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 4-amino-1-benzylpiperidine compounds
- Patent number 7,368,463
- Issue date May 6, 2008
- Theravance, Inc.
- Mathai Mammen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds
- Patent number 7,285,564
- Issue date Oct 23, 2007
- Theravance, Inc.
- Mathai Mammen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of aryl aniline β2 adrenergic receptor agonist
- Patent number 7,060,712
- Issue date Jun 13, 2006
- Theravance, Inc.
- Sabine Axt
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS
- Publication number 20190119267
- Publication date Apr 25, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS
- Publication number 20150291579
- Publication date Oct 15, 2015
- THERAVANCE BIOPHARMA R&D IP, LLC
- Daniel D. Long
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARING AN INTERMEDIATE TO MU OPIOID RECEPTOR ANTAGON...
- Publication number 20130079523
- Publication date Mar 28, 2013
- Theravance, Inc.
- Pierre-Jean Colson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARING AN INTERMEDIATE TO MU OPIOID RECEPTOR ANTAGON...
- Publication number 20110166355
- Publication date Jul 7, 2011
- Theravance, Inc.
- Pierre-Jean Colson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORM OF A BETA2 ADRENERGIC RECEPTOR AGONIST
- Publication number 20100125150
- Publication date May 20, 2010
- Theravance, Inc.
- Ioanna Stergiades
- C07 - ORGANIC CHEMISTRY
Information Patent Application
8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS
- Publication number 20100035921
- Publication date Feb 11, 2010
- Theravance, Inc.
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substituted 4-amino-benzylpiperidine compounds
- Publication number 20090023777
- Publication date Jan 22, 2009
- Mathai Mammen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for preparing an intermediate to opioid receptor antagonists
- Publication number 20090023934
- Publication date Jan 22, 2009
- Pierre-Jean Colson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
8-Azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
- Publication number 20070219278
- Publication date Sep 20, 2007
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Crystalline form of beta2 adrenergic receptor agonist
- Publication number 20070155990
- Publication date Jul 5, 2007
- Ioanna Stergiades
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted 4-amino-1-benzylpiperidine compounds
- Publication number 20050026954
- Publication date Feb 3, 2005
- Mathai Mammen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Crystalline form of beta2 adrenergic receptor agonist
- Publication number 20040248985
- Publication date Dec 9, 2004
- Ioanna Stergiades
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Crystalline form of aryl aniline beta-2 adrenergic receptor agonist
- Publication number 20040224982
- Publication date Nov 11, 2004
- Sabine Axt
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds
- Publication number 20040122014
- Publication date Jun 24, 2004
- Mathai Mammen
- C07 - ORGANIC CHEMISTRY

Ioanna Stergiades

Person

Patents Grantslast 30 patents

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Process for preparing an intermediate to mu opioid receptor antagon...

8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists

Process for preparing an intermediate to mu opioid receptor antagon...

Substituted 4-amino-benzylpiperidine compounds

Process for preparing an intermediate to opioid receptor antagonists

Crystalline form of a β2 adrenergic receptor agonist

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Crystalline form of β2 adrenergic receptor agonist

Substituted 4-amino-1-benzylpiperidine compounds

Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds

Crystalline form of aryl aniline β2 adrenergic receptor agonist

Patents Applicationslast 30 patents

8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS

8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS

PROCESS FOR PREPARING AN INTERMEDIATE TO MU OPIOID RECEPTOR ANTAGON...

PROCESS FOR PREPARING AN INTERMEDIATE TO MU OPIOID RECEPTOR ANTAGON...

CRYSTALLINE FORM OF A BETA2 ADRENERGIC RECEPTOR AGONIST

8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS

Substituted 4-amino-benzylpiperidine compounds

Process for preparing an intermediate to opioid receptor antagonists

8-Azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Crystalline form of beta2 adrenergic receptor agonist

Substituted 4-amino-1-benzylpiperidine compounds

Crystalline form of beta2 adrenergic receptor agonist

Crystalline form of aryl aniline beta-2 adrenergic receptor agonist

Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds